Repeated monthly epicutaneous challenges with diphenylcyclopropenone result in a clinically reproducible level of contact allergy in de novo sensitized individuals-Reference-Cited by-同舟云学术

Repeated monthly epicutaneous challenges with diphenylcyclopropenone result in a clinically reproducible level of contact allergy in de novo sensitized individuals

Published:2017-02-07 Issue:4 Volume:176 Page:1095-1097
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Mose K.F.¹²,Andersen F.¹²,Skov L.³,Røpke M.A.⁴,Litman T.⁴⁵,Friedmann P.S.⁶,Andersen K.E.¹²⁷

Affiliation:

1. Department of Dermatology and Allergy Centre; Odense University Hospital; University of Southern Denmark; 5000 Odense C Denmark

2. Dermatological Investigations Scandinavia; Odense University Hospital; University of Southern Denmark; 5000 Odense C Denmark

3. Department of Dermato-Allergology; Herlev and Gentofte Hospital; University of Copenhagen; 2900 Hellerup Denmark

4. LEO Pharma A/S; Departments of Clinical Pharmacology and Molecular Biomedicine; 2750 Ballerup Denmark

5. Department of Immunology and Microbiology; University of Copenhagen; 2200 Copenhagen N Denmark

6. Division of Infection, Inflammation and Immunity; University of Southampton School of Medicine; Southampton U.K.

7. Centre for Innovative Medical Technology; Institute of Clinical Research; Odense University Hospital; University of Southern Denmark; 5000 Odense C Denmark

Funder

LEO Pharma Research Foundation

Region of Southern Denmark

Syddansk Universitet

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.14949/fullpdf

Reference7 articles.

1. Diphenylcyclopropenone in patients with alopecia areata. A critically appraised topic;Kuin;Br J Dermatol,2015